PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-17.49%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-70.11%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-5.29%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
14.79%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
-22.85%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.75%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-27.25%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-30.44%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-9.26%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
14.94%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
-5.71%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
14.27%
Similar operating margin growth to CRWD's 14.45%. Walter Schloss would investigate industry trends.
23.49%
Other expenses growth 1.1-1.25x CRWD's 18.80%. Bill Ackman would demand expense justification.
-2.01%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
18.76%
Similar pre-tax margin growth to CRWD's 24.73%. Walter Schloss would investigate industry trends.
-4.81%
Both companies reducing tax expense. Martin Whitman would check patterns.
-0.50%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
20.59%
Net margin growth 50-75% of CRWD's 33.47%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.57%
Share count reduction below 50% of CRWD's 0.59%. Michael Burry would check for concerns.
0.11%
Diluted share reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.